Khuri FR - Search Results

1

MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development.

Harati S, Cooper LA, Moran JD, Giuste FO, Du Y, Ivanov AA, Johns MA, Khuri FR, Fu H, Moreno CS. Harati S, et al. Among authors: khuri fr. PLoS One. 2017 Jan 24;12(1):e0170339. doi: 10.1371/journal.pone.0170339. eCollection 2017. PLoS One. 2017. PMID: 28118365 Free PMC article.

2

The farnesyltransferase inhibitor Lonafarnib induces growth arrest or apoptosis of human lung cancer cells without downregulation of Akt.

Sun SY, Zhou Z, Wang R, Fu H, Khuri FR. Sun SY, et al. Among authors: khuri fr. Cancer Biol Ther. 2004 Nov;3(11):1092-8; discussion 1099-1101. doi: 10.4161/cbt.3.11.1176. Epub 2004 Nov 12. Cancer Biol Ther. 2004. PMID: 15467440 Free article.

3

Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.

Sun SY, Rosenberg LM, Wang X, Zhou Z, Yue P, Fu H, Khuri FR. Sun SY, et al. Among authors: khuri fr. Cancer Res. 2005 Aug 15;65(16):7052-8. doi: 10.1158/0008-5472.CAN-05-0917. Cancer Res. 2005. PMID: 16103051

4

Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways.

Porter GW, Khuri FR, Fu H. Porter GW, et al. Among authors: khuri fr. Semin Cancer Biol. 2006 Jun;16(3):193-202. doi: 10.1016/j.semcancer.2006.03.003. Epub 2006 Apr 1. Semin Cancer Biol. 2006. PMID: 16697216 Review.

5

Monitoring 14-3-3 protein interactions with a homogeneous fluorescence polarization assay.

Du Y, Masters SC, Khuri FR, Fu H. Du Y, et al. Among authors: khuri fr. J Biomol Screen. 2006 Apr;11(3):269-76. doi: 10.1177/1087057105284862. J Biomol Screen. 2006. PMID: 16699128

6

14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells.

Dong S, Kang S, Gu TL, Kardar S, Fu H, Lonial S, Khoury HJ, Khuri F, Chen J. Dong S, et al. Blood. 2007 Jul 1;110(1):360-9. doi: 10.1182/blood-2006-12-065615. Epub 2007 Mar 27. Blood. 2007. PMID: 17389761 Free PMC article.

7

Targeting mTOR signaling for lung cancer therapy.

Sun SY, Fu H, Khuri FR. Sun SY, et al. Among authors: khuri fr. J Thorac Oncol. 2006 Feb;1(2):109-11. J Thorac Oncol. 2006. PMID: 17409838 Free article. Review. No abstract available.

8

Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.

Wang X, Yue P, Chan CB, Ye K, Ueda T, Watanabe-Fukunaga R, Fukunaga R, Fu H, Khuri FR, Sun SY. Wang X, et al. Among authors: khuri fr. Mol Cell Biol. 2007 Nov;27(21):7405-13. doi: 10.1128/MCB.00760-07. Epub 2007 Aug 27. Mol Cell Biol. 2007. PMID: 17724079 Free PMC article.

9

Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation.

Li Z, Zhao J, Du Y, Park HR, Sun SY, Bernal-Mizrachi L, Aitken A, Khuri FR, Fu H. Li Z, et al. Among authors: khuri fr. Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):162-7. doi: 10.1073/pnas.0710905105. Epub 2007 Dec 27. Proc Natl Acad Sci U S A. 2008. PMID: 18162532 Free PMC article.

10

Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin.

Kasinski AL, Du Y, Thomas SL, Zhao J, Sun SY, Khuri FR, Wang CY, Shoji M, Sun A, Snyder JP, Liotta D, Fu H. Kasinski AL, et al. Among authors: khuri fr. Mol Pharmacol. 2008 Sep;74(3):654-61. doi: 10.1124/mol.108.046201. Epub 2008 Jun 24. Mol Pharmacol. 2008. PMID: 18577686 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

497 results

Search Page

Filters